keyword
https://read.qxmd.com/read/38713894/neoantigen-landscape-supports-feasibility-of-personalized-cancer-vaccine-for-follicular-lymphoma
#1
JOURNAL ARTICLE
Cody A Ramirez, Michelle Becker-Hapak, Kartik Singhal, David A Russler-Germain, Felix Frenkel, Erica K Barnell, Ethan McClain, Sweta Desai, Timothy Schappe, Onyinyechi C Onyeador, Olga Kudryashova, Vladislav Belousov, Alexander Bagaev, Elena Ocheredko, Susanna Kiwala, Jasreet Hundal, Zachary L Skidmore, Marcus P Watkins, Thomas B Mooney, Jason Walker, Kilannin Krysiak, Felicia Gomez, Catrina C Fronick, Robert S Fulton, Robert D Schreiber, Neha Mehta-Shah, Amanda F Cashen, Brad S Kahl, Ravshan Ataullakhanov, Nancy L Bartlett, Malachi Griffith, Obi L Griffith, Todd A Fehniger
Personalized cancer vaccines designed to target neoantigens represent a promising new treatment paradigm in oncology. In contrast to classical idiotype vaccines, we hypothesized that 'polyvalent' vaccines could be engineered for the personalized treatment of follicular lymphoma (FL) using neoantigen discovery by combined whole exome sequencing (WES) and RNA sequencing (RNA-Seq). Fifty-eight tumor samples from 57 patients with FL underwent WES and RNA-Seq. Somatic and B-cell clonotype neoantigens were predicted and filtered to identify high-quality neoantigens...
May 7, 2024: Blood Advances
https://read.qxmd.com/read/38713892/facial-features-of-hereditary-cancer-predisposition
#2
REVIEW
Ari Horton, William Fostier, Ingrid Winship, Neil Rajan
In the age of telehealth medicine, an individual's facial features may provide the only physical clues signaling the presence of a heritable cancer predisposition syndrome. These syndromes include APC -associated polyposis, Birt-Hogg-Dubé syndrome, CYLD cutaneous syndrome, hereditary leiomyomatosis and renal cell cancer, multiple endocrine neoplasia, neurofibromatosis type 1, Peutz-Jeghers syndrome, PTEN hamartoma tumor syndrome, and tuberous sclerosis complex 1 and 2, among others. Correctly identifying characteristic features is important for genetic and nongenetic specialists as early detection can enable prompt intervention, improving patient outcomes...
May 7, 2024: JCO oncology practice
https://read.qxmd.com/read/38713724/use-of-antiviral-drugs-and-incidence-of-parkinson-s-disease-in-taiwan
#3
JOURNAL ARTICLE
Han-Wei Zhang, Jun Xie, Hsiao-Ching Peng, Yu-Shan Lin, Ji-Quan Song
Patients infected with herpes zoster might be at risk for Parkinson's disease (PD). However, antiviral drugs may impede viral deoxyribonucleic acid (DNA) synthesis. This study aimed to determine whether the currently observed association between herpes zoster and PD is consistent with previous findings, and whether antiviral drug use is associated with PD. This retrospective cohort study used the Longitudinal Generation Tracking Database. We included patients aged 40 years and above and applied propensity score matching at 1:1 ratio for study comparability...
2024: PloS One
https://read.qxmd.com/read/38713670/validity-of-claims-based-definition-of-number-of-remaining-teeth-in-japan-results-from-the-longevity-improvement-and-fair-evidence-study
#4
JOURNAL ARTICLE
Yudai Tamada, Taro Kusama, Sachiko Ono, Megumi Maeda, Fumiko Murata, Ken Osaka, Haruhisa Fukuda, Kenji Takeuchi
BACKGROUND: Secondary healthcare data use has been increasing in the dental research field. The validity of the number of remaining teeth assessed from Japanese dental claims data has been reported in several studies, but has not been tested in the general population in Japan. OBJECTIVES: To evaluate the validity of the number of remaining teeth assessed from Japanese dental claims data and assess its predictability against subsequent health deterioration. METHODS: We used the claims data of residents of a municipality that implemented oral health screening programs...
2024: PloS One
https://read.qxmd.com/read/38713628/themis-promotes-t-cell-development-and-maintenance-by-rising-the-signaling-threshold-of-the-inhibitory-receptor-btla
#5
JOURNAL ARTICLE
Suzanne Mélique, Aurélie Vadel, Nelly Rouquié, Cui Yang, Cyrielle Bories, Coline Cotineau, Abdelhadi Saoudi, Nicolas Fazilleau, Renaud Lesourne
The current paradigm about the function of T cell immune checkpoints is that these receptors switch on inhibitory signals upon cognate ligand interaction. We here revisit this simple switch model and provide evidence that the T cell lineage protein THEMIS enhances the signaling threshold at which the immune checkpoint BTLA (B- and T-lymphocyte attenuator) represses T cell responses. THEMIS is recruited to the cytoplasmic domain of BTLA and blocks its signaling capacity by promoting/stabilizing the oxidation of the catalytic cysteine of the tyrosine phosphatase SHP-1...
May 14, 2024: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/38713518/neuronal-damps-exacerbate-neurodegeneration-via-astrocytic-ripk3-signaling
#6
JOURNAL ARTICLE
Nydia P Chang, Evan M DaPrano, Marissa Lindman, Irving Estevez, Tsui-Wen Chou, Wesley R Evans, Marialaina Nissenbaum, Micheal McCourt, Diego Alzate, Colm Atkins, Alexander W Kusnecov, Rafiq Huda, Brian P Daniels
Astrocyte activation is a common feature of neurodegenerative diseases. However, the ways in which dying neurons influence the activity of astrocytes is poorly understood. Receptor interacting protein kinase-3 (RIPK3) signaling has recently been described as a key regulator of neuroinflammation, but whether this kinase mediates astrocytic responsiveness to neuronal death has not yet been studied. Here, we used the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of Parkinson's disease to show that activation of astrocytic RIPK3 drives dopaminergic cell death and axon damage...
May 7, 2024: JCI Insight
https://read.qxmd.com/read/38713350/improvement-strategy-of-citrate-and-biochar-assisted-nano-palladium-iron-composite-for-effective-dechlorination-of-2-4-dichlorophenol
#7
JOURNAL ARTICLE
Hongyi Zhou, Longfei Lv, Mengyao Ye, Shams Ali Baig, Yangchun Luo, Jinhai Chen, Shufen Hu, Hao Zhang, Junliang Wang
Rapid passivation and aggregation of nanoscale zero-valent iron (nZVI) seriously limit its performance in the remediation of different contaminants from wastewater. To overcome such issues, in the present study, nano-palladium/iron (nPd/Fe) was simultaneously improved by biochar (BC) prepared from discarded peanut shells and green complexing agent sodium citrate (SC). For this purpose, a composite (SC-nPd/Fe@BC) was successfully synthesized to remove 2,4-dichlorophenol (2,4-DCP) from wastewater. In the SC-nPd/Fe@BC, BC acts as a carrier with dispersed nPd/Fe particles to effectively prevent its agglomeration, and increased the specific surface area of the composite, thereby improving the reactivity and stability of nPd/Fe...
May 7, 2024: Environmental Science and Pollution Research International
https://read.qxmd.com/read/38713335/isolated-rheumatic-tricuspid-valve-regurgitation-it-is-only-rare-not-just-a-myth-rare-case-report
#8
JOURNAL ARTICLE
Vemmy Lian Saputri, Valerinna Yogibuana
BACKGROUND: Isolated rheumatic tricuspid regurgitation (IRTR) is a rare condition that can manifest as right heart failure (RHF) and pulmonary hypertension (PH) symptoms. Diagnosing and treating IRTR in cases of latent RHD can be a challenge and crucial for future research to establish new guidelines for echocardiography in RHD that focus not only on the mitral and aorta but also the tricuspid valve. CASE PRESENTATION: A young female patient with clinical symptoms of RHF suspected IRTR due to latent RHD from echocardiography...
May 7, 2024: Egyptian Heart Journal: EHJ
https://read.qxmd.com/read/38713217/long-term-survival-after-anti-pd-1-discontinuation-in-advanced-cutaneous-squamous-cell-carcinoma-cscc-a-proof-of-concept-of-benefit-of-concomitant-cemiplimab-and-radiotherapy
#9
JOURNAL ARTICLE
Barbara Bailly-Caillé, Romain Levard, Diane Kottler, Anne Dompmartin, Jean-Matthieu L'Orphelin
BACKGROUND: In a princeps study we conducted in patients with advanced cutaneous squamous cell carcinoma treated with concomitant anti-Programmed cell death protein 1 (PD-1) and radiotherapy, we demonstrated a clinico radiological response to cemiplimab that appeared to persist over time, 1 year after treatment discontinuation. METHOD: We conducted a single-center descriptive study at Caen Hospital from September 1, 2021 to September 2023, in 14 patients with advanced carcinoma treated with cemiplimab until September 1, 2021...
May 7, 2024: Cancer Immunology, Immunotherapy: CII
https://read.qxmd.com/read/38713163/development-of-inhibitors-probes-and-protac-provides-a-complete-toolbox-to-study-park7-in-the-living-cell
#10
JOURNAL ARTICLE
Yuqing Jia, Merve Oyken, Robbert Q Kim, Rayman T N Tjokrodirijo, Arnoud H de Ru, Antonius P A Janssen, Stephan M Hacker, Peter A van Veelen, Paul P Geurink, Aysegul Sapmaz
The integration of diverse chemical tools like small-molecule inhibitors, activity-based probes (ABPs), and proteolysis targeting chimeras (PROTACs) advances clinical drug discovery and facilitates the exploration of various biological facets of targeted proteins. Here, we report the development of such a chemical toolbox for the human Parkinson disease protein 7 (PARK7/DJ-1) implicated in Parkinson's disease and cancers. By combining structure-guided design, miniaturized library synthesis, and high-throughput screening, we identified two potent compounds, JYQ-164 and JYQ-173 , inhibiting PARK7 in vitro and in cells by covalently and selectively targeting its critical residue, Cys106...
May 7, 2024: Journal of Medicinal Chemistry
https://read.qxmd.com/read/38712850/isatuximab-plus-pomalidomide-and-dexamethasone-in-patients-with-relapsed-refractory-multiple-myeloma-in-real-world-the-retrospective-image-study
#11
JOURNAL ARTICLE
Olivier Decaux, Jean Fontan, Aurore Perrot, Lionel Karlin, Cyrille Touzeau, Samantha Schulmann, Salomon Manier, Karim Belhadj, Adrien Trebouet, Patricia Zunic, Jean-Marc Schiano De Colella, Brice Castel, Zoé Van De Wyngaert, Gian Matteo Pica, Mourad Tiab, Frédérique Kuhnowski, Malek Bouketouche, Sophia Rigaudeau, Riad Benramdane, Christina Tekle, Radhia Lafore, Marianne Gaucher, Jill Corre, Xavier Leleu
BACKGROUND: IMAGE is a retrospective cohort study of patients enrolled in early access programs (EAPs) in France with relapsed/refractory multiple myeloma (RRMM) receiving isatuximab with pomalidomide and dexamethasone (Isa-Pd). METHODS: Patients aged ≥18 years with RRMM who received ≥1 dose of Isa under the EAPs between July 29, 2019 and August 30, 2020 were included. Effectiveness endpoints included progression-free survival (PFS) and response rates...
May 7, 2024: European Journal of Haematology
https://read.qxmd.com/read/38712840/iridium-iii-complexes-conjugated-with-naproxen-exhibit-potent-anti-tumor-activities-by-inducing-mitochondrial-damage-modulating-inflammation-and-enhancing-immunity
#12
JOURNAL ARTICLE
Kai Xie, Xing-Yun Lu, Hou Zhu, Lin-Yuan Zhu, Rong-Tao Li, Rui-Rong Ye
A series of Ir(III)-naproxen (NPX) conjugates with the molecular formula [Ir(C^N)2 bpy(4-CH2 ONPX-4'-CH2 ONPX)](PF6 ) (Ir-NPX-1-3) were designed and synthesized, including C^N = 2-phenylpyridine (ppy, Ir-NPX-1), 2-(2-thienyl)pyridine (thpy, Ir-NPX-2) and 2-(2,4-difluorophenyl)pyridine (dfppy, Ir-NPX-3). Cytotoxicity tests showed that Ir-NPX-1-3 exhibited excellent antitumor activity, especially in A549R cells. The cellular uptake experiment showed that the complexes were mainly localized in mitochondria, and induced apoptosis in A549R cells by damaging the structure and function of mitochondria...
May 7, 2024: Dalton Transactions: An International Journal of Inorganic Chemistry
https://read.qxmd.com/read/38712768/mice-with-nop2-sun-rna-methyltransferase-5-deficiency-die-before-reaching-puberty-due-to-fatal-kidney-damage
#13
JOURNAL ARTICLE
Hongya Zhang, Xiaohui Li, Jing Bai, Cong Zhang
BACKGROUND: NOP2/Sun RNA methyltransferase 5 (NSUN5) is an RNA methyltransferase that has a broad distribution and plays critical roles in various biological processes. However, our knowledge of the biological functions of NSUN5 in mammals is very limited. Therefore, in this study, we investigate the role of NSUN5 in mice. METHODS: In the present research, we built a mouse model (Nsun5-/- ) using the CRISPR/Cas9 system to investigated the specific role of NSUN5...
December 2024: Renal Failure
https://read.qxmd.com/read/38712709/collaborative-care-approaches-for-people-with-severe-mental-illness
#14
REVIEW
Siobhan Reilly, Charley Hobson-Merrett, Bliss Gibbons, Ben Jones, Debra Richards, Humera Plappert, John Gibson, Maria Green, Linda Gask, Peter J Huxley, Benjamin G Druss, Claire L Planner
BACKGROUND: Collaborative care for severe mental illness (SMI) is a community-based intervention that promotes interdisciplinary working across primary and secondary care. Collaborative care interventions aim to improve the physical and/or mental health care of individuals with SMI. This is an update of a 2013 Cochrane review, based on new searches of the literature, which includes an additional seven studies. OBJECTIVES: To assess the effectiveness of collaborative care approaches in comparison with standard care (or other non-collaborative care interventions) for people with diagnoses of SMI who are living in the community...
May 7, 2024: Cochrane Database of Systematic Reviews
https://read.qxmd.com/read/38712706/triune-nanomodulator-enables-exhausted-cytotoxic-t-lymphocyte-rejuvenation-for-cancer-epigenetic-immunotherapy
#15
JOURNAL ARTICLE
Junhua Li, Quan Zhao, Nan Zhang, Lihuang Wu, Qiusheng Wang, Jing Li, Qingqing Pan, Yuji Pu, Kui Luo, Zhongwei Gu, Bin He
Oncogene activation and epigenome dysregulation drive tumor initiation and progression, contributing to tumor immune evasion and compromising the clinical response to immunotherapy. Epigenetic immunotherapy represents a promising paradigm in conquering cancer immunosuppression, whereas few relevant drug combination and delivery strategies emerge in the clinic. This study presents a well-designed triune nanomodulator, termed ROCA, which demonstrates robust capabilities in tumor epigenetic modulation and immune microenvironment reprogramming for cancer epigenetic immunotherapy...
May 7, 2024: ACS Nano
https://read.qxmd.com/read/38712566/a-sustainable-strategic-approach-for-n-alkylation-of-amines-with-activation-of-alcohols-triggered-via-a-hydrogen-auto-transfer-reaction-using-a-pd-ii-complex-evidence-for-metal-ligand-cooperativity
#16
JOURNAL ARTICLE
Virendra Kumar Chaudhary, Prashant Kukreti, Keshav Sharma, Kapil Kumar, Sain Singh, Sheela Kumari, Kaushik Ghosh
This work describes a new well-defined, air-stable, phosphine free palladium(II) [Pd(L)Cl] (1) catalyst. This catalyst was utilized for N -alkylation of amines and indole synthesis where H2 O was found to be the by-product. A broad range of aromatic amines were alkylated using this homogeneous catalyst with a catalyst loading of 0.1 mol%. Greener aromatic and aliphatic primary alcohols were utilized and a hydrogen auto-transfer strategy via a metal-ligand cooperative approach was investigated. The precursor of the antihistamine-containing drug molecule tripelennamine was synthesized on a gram scale for large-scale applicability of the current synthetic methodology...
May 7, 2024: Dalton Transactions: An International Journal of Inorganic Chemistry
https://read.qxmd.com/read/38712379/synthesis-and-catalytic-properties-of-palladium-ii-complexes-with-p-%C3%AF-chelating-ferrocene-phosphinoallyl-ligands-and-their-non-tethered-analogues
#17
JOURNAL ARTICLE
Karel Škoch, Jakub Antala, Ivana Císařová, Petr Štěpnička
Hybrid phosphines usually combine a phosphine moiety with another heteroatom secondary donor group in their structures while compounds equipped with hydrocarbyl π-donor moieties remain uncommon. This contribution reports the synthesis and structural characterization of the first P/π-allyl-chelating complexes that were obtained using the structurally flexible and redox-active ferrocene unit as the scaffold, viz . [PdCl(R2 PfcCHCHCH2 -η3 :κ P )] (1R; R = Ph and cyclohexyl (Cy); fc = ferrocene-1,1'-diyl)...
May 7, 2024: Dalton Transactions: An International Journal of Inorganic Chemistry
https://read.qxmd.com/read/38712312/pembrolizumab-induced-asthma-exacerbation-with-hypereosinophilia-and-elevated-interleukin-5-in-endometrial-cancer-a-case-report
#18
Tomoya Harada, Naoki Uetani, Genki Inui, Hiroki Ishikawa, Yoshihiro Funaki, Miki Takata, Ryota Okazaki, Kosuke Yamaguchi, Masato Morita, Shin Kitatani, Akira Yamasaki
Pembrolizumab is an anti-programmed cell death-1 (PD-1) antibody used to treat various cancer types. Treatments with such immune checkpoint inhibitors cause immune-related adverse events. However, airway inflammation caused by immune-related adverse events has rarely been reported. A 54-year-old woman with endometrial cancer experienced asthma exacerbation, and increased blood eosinophil counts 3 months after pembrolizumab administration. Although asthma exacerbation improved, the resumption of pembrolizumab caused the recurrence of dry cough and hypereosinophilia...
2024: Respiratory Medicine Case Reports
https://read.qxmd.com/read/38712260/ca-2-dependent-phosphodiesterase-1-regulates-the-plasticity-of-striatal-spiny-projection-neuron-glutamatergic-synapses
#19
Shenyu Zhai, Shintaro Otsuka, Jian Xu, Vernon R J Clarke, Tatiana Tkatch, David Wokosin, Zhong Xie, Asami Tanimura, Hitesh K Agarwal, Graham C R Ellis-Davies, Anis Contractor, D James Surmeier
Long-term synaptic plasticity at glutamatergic synapses on striatal spiny projection neurons (SPNs) is central to learning goal-directed behaviors and habits. Although considerable attention has been paid to the mechanisms underlying synaptic strengthening and new learning, little scrutiny has been given to those involved in the attenuation of synaptic strength that attends suppression of a previously learned association. Our studies revealed a novel, non-Hebbian, long-term, postsynaptic depression of glutamatergic SPN synapses induced by interneuronal nitric oxide (NO) signaling (NO-LTD) that was preferentially engaged at quiescent synapses...
April 25, 2024: bioRxiv
https://read.qxmd.com/read/38712112/radiomic-analysis-of-patient-and-inter-organ-heterogeneity-in-response-to-immunotherapies-and-braf-targeted-therapy-in-metastatic-melanoma
#20
Alexandra Tompkins, Zane N Gray, Rebekah E Dadey, Serafettin Zenkin, Nasim Batavani, Sarah Newman, Afsaneh Amouzegar, Murat Ak, Nursima Ak, Taha Yasin Pak, Vishal Peddagangireddy, Priyadarshini Mamindla, Sarah Behr, Amy Goodman, Darcy L Ploucha, John M Kirkwood, Hassane M Zarour, Yana G Najjar, Diwakar Davar, Rivka Colen, Jason J Luke, Riyue Bao
BACKGROUND: Variability in treatment response may be attributable to organ-level heterogeneity in tumor lesions. Radiomic analysis of medical images can elucidate non-invasive biomarkers of clinical outcome. Organ-specific radiomic comparison across immunotherapies and targeted therapies has not been previously reported. METHODS: We queried UPMC Hillman Cancer Center registry for patients with metastatic melanoma (MEL) treated with immune checkpoint inhibitors (ICI) (anti-PD1/CTLA4 [ipilimumab+nivolumab; I+N] or anti-PD1 monotherapy) or BRAF targeted therapy...
April 27, 2024: medRxiv
keyword
keyword
79724
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.